Report: China leads the way with phase 1 studies
Novotech, an Asia Pacific biotech CRO, has published a new global report on phase 1…
Novotech, an Asia Pacific biotech CRO, has published a new global report on phase 1…
The companies Asimov, BioRay Pharmaceuticals and Colossal Biosciences bagged the biggest biotech investments in January…
Masahiko Hayakawa, head of targeted protein degradation at Astellas Pharma Inc., gives us some insights…
A license agreement has been signed between Helsinn Group and Juniper Biologics further widening the…
All of Everest Medicine's development and commercialization rights for a breast cancer drug called Trodelvy…
China’s vaccine developer MaxHealth Biotechnology raised the biggest private biotech investment in the Asia-Pacific region…
Intervenn Biosciences is expanding across Asia-Pacific and North America and opening new facilities in Kuala…
The lab automation player MegaRobo stole the show in the Asia-Pacific region in June with…